Biomea Fusion Inc reports results for the quarter ended December 31 - Earnings Summary

• Biomea Fusion Inc BMEA.OQ reported a quarterly adjusted loss of 81 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -98 cents. The mean expectation of nine analysts for the quarter was for a loss of 92 cents per share. Wall Street expected results to range from $-1.20 to -77 cents per share.

• Reported revenue was zero​; analysts expected zero.

• Biomea Fusion Inc's reported EPS for the quarter was a loss of 81 cents​.

• The company reported a quarterly loss of $29.3 million.

• Biomea Fusion Inc shares had held steady so far this quarter and lost 45.1% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for Biomea Fusion Inc is $20.50

This summary was machine generated from LSEG data April 1 at 01:30 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)